Purpose: This study aimed to investigate the prevalence of delayed thyroid dysfunc tion based on iodine disinfectant use and to analyze associated risk factors. Methods: A retrospective study was conducted on late preterm infants admitted to the neonatal intensive care unit between January 2010 and June 2018, who under went neonatal thyroid screening (NTS) and ≥2 thyroid function tests (TFTs). NTS was performed 3 days after birth, with at least two TFTs 1 week and 2 to 4 weeks after birth. To distinguish between normal and dysfunctional thyroid levels, we reviewed TFT results at 2 to 4 weeks and examined possible risk factors for the development of thyroid dysfunction. Results: Of 295 late preterm infants, 262 were enrolled with a mean gestational age and birth weight of 34.8±0.7 weeks and 2,170±454 g, respectively. A total of 7.6% de veloped hyperthyrotropinemia at the age of 24.3±14.6 days (range, 12 to 69). The in cidence of hyperthyrotropinemia during iodine use was approximately 12.6%, while that during discontinuation was 2.4% (P=0.002). Multivariate analysis revealed that small for gestational age (SGA), iodine disinfectant use, and abnormal NTS results were significant risk factors for delayed hyperthyrotropinemia (adjusted odds ratio [AOR]: 4.27, P=0.008; AOR: 8.24, P=0.003; and AOR: 7.80, P=0.002, respectively). Conclusion: Delayed hyperthyrotropinemia was prevalent in late preterm infants exposed to topical iodine and those identified as being SGA. Secondary TFTs should be considered 2 to 4 weeks after birth for this population at risk.
INTRODUCTION
Late preterm infants (born at 34 to 36 weeks gestation) account for approximately 80% of preterm infants worldwide and are expected to occupy a relatively high percentage of the population in the coming years 1) . This group had been called "near term" but was renamed as "late preterm, " recognizing the importance of the development in the last 6 weeks of pregnancy 24) . Over the past 10 years, some studies have observed delayed development and cognitive decline in late preterm infants 57) .
However, it is difficult to determine the factors that contribute to this delayed development since hospitalization criteria for these patients differ across units 8, 9) and these infants are often not followed. A study conducted by Cuestas et al. 10) showed that these infants are significantly disadvantaged due to the longterm effects of hyperthyrotropinemia that persist until childhood.
Thyroid hormones play a diverse role in the maintenance of homeostasis and are critical for neurodevelopment, particularly during the fetal and neonatal periods 11) . Hypothyroidism during this period can cause unrecognized cognitive disorders; however, with the introduction of neonatal thyroid screening (NTS) poli cies, these irreversible cognitive impairments can now be signifi cantly minimized to prevent further medical complications 12) . However, data gathered over the past two decades suggest that due to delayed thyroid dysfunction in premature infants, one NTS program is insufficient to estimate the effects on future de velopment. Delayed thyroid dysfunction is known to develop due to hypothalamuspituitarythyroid axis immaturity, various diseases, and use of medications, including topical iodine, in premature infants 13) . Therefore, it is highly recommended that hospitals perform repeat thyroid function tests (TFTs) in ex tremely premature infants 1417) . In practice, clinicians tend to conduct followups regularly according to these guidelines for extremely early premature infants but not for late premature infants.
In relation to this institution's neonatal intensive care unit (NICU), the authors reported that patients had been exposed to iodine disinfectant before blood, cerebrospinal fluid, and urine culture tests; central line insertions; and periodic dress ings. Given that there are many late preterm neonates, it is important to identify their individual physiology and formulate specific follow up guidelines for improved outcomes. Due to a heightened awareness of this existing issue, medical staff aims to prevent iodine overload by implementing the institution's infection control guidelines enacted in 2015, which substituted the standard iodine disinfectant with 0.5% to 2% chlorhexidine gluconate.
The primary purpose of this preliminary study was to compare the prevalence of thyroid dysfunction during the use and discon tinuation of iodine disinfectants to determine its effects on the thyroid function of late preterm neonates. Furthermore, we analyzed specific risk factors to establish the basis of patient fol lowup guidelines, with heightened consideration of thyroid hormone effects on neurodevelopment. 
MATERIALS AND METHODS

Design
NTS
NTS was performed on the third day after birth using thyroid stimulating hormone (TSH). Capillary blood spots were soaked in filter paper designed for neonatal screening and dried at room temperature. These were examined with fluoroimmunoassay using VICTOR2 TM D or AutoDELFIA (PerkinElmer, Wallac Oy, Finland). According to the laboratory criteria, TSH levels ≥10 µIU/mL were classified as abnormal and reevaluated by TFTs.
TFTs
All premature infants who were admitted to the NICU under went at least two TFTs, including measurement of TSH and free thyroxine (FT4) levels. TFT was first performed 1 week after birth and was again performed in the 2nd to 4th week regardless of previous results. Serum FT4 and TSH levels were measured by chemiluminescent microparticle immunoassay using Architect i2000SR (Abbott Laboratories, Abbott Park, IL, USA). The refer ence FT4 level was 0.7 to 1.48 ng/dL. When the first TFT result showed FT4 levels <0.7 ng/dL and TSH levels >20 µU/mL, hypo thyroidism was confirmed and levothyroxine (LT4) therapy was initiated at a dose of 10 to 15 µg/kg. Cutoff values in the second TFT performed at 2 to 4 weeks after birth were as follows: follow up termination for normal FT4 levels and TSH level <5 µU/mL; followup after 2 weeks for normal FT4 levels and TSH level of 5 to 10 µU/mL; and TSH levels ≥10 µU/mL were referred to endo crinologists and LT4 treatment was initiated. To determine whether preterm infant hospitalization into the NICU was necessary and warranted, we considered the following criteria: GA <35 weeks, birth weight <2 kg, and the presence of certain acute problems such as respiratory distress, hypoglyce mia, infection, and potential feeding disorders. While there were no changes in treatment guidelines for late premature infants in this study, there was a change in disinfectant type and use.
Data collection and outcome measurement
Small for gestational age (SGA) was defined as birth weight lower than the 10th percentile for sex and GA 19) . The first echo cardiography was performed 3 to 7 days after birth to confirm the presence of patent ductus arteriosus (PDA). Intraventricular hemorrhage was defined according to the classifica tion by Papile et al. 20) . Bronchopulmonary dysplasia was diagnosed when oxy gen was required for >4 weeks after birth 21) .
Time of diagnosis and TFTs in the thyroid dysfunction group was examined and divided into two distinctive time periods:
iodine disinfectant use (period 1, January 2010 to February 2015)
and iodine disinfectant discontinuation (period 2, March 2015 to June 2018). These individual periods were used to assess iodine use in the analysis of risk factors for thyroid dysfunction. 
Statistical analysis
RESULTS
Study participants
We included 262 of 295 late preterm infants who underwent ≥2 TFTs ( Figure 1 ). The most frequent cause of hospitalization was respiratory distress (77.5%), followed by GA <35 weeks (56.5%) 
Thyroid dysfunction
Risk factors
The variables used in the multiple logistic regression analysis were as follows: low birth weight (<2,000 g), male sex, SGA, pre sence of PDA, period 1, and abnormal NTS result, as these factors 
DISCUSSION
Thyroid dysfunction was noted in 7.6% of late premature infants 2 weeks after birth, and all were hyperthyrotropinemia.
Additionally, delayed thyrotropin level elevation occurred in 5.8% of patients who showed normal NTS result. The incidence of thyroid dysfunction during iodine administration was 12.6%, while that during iodine discontinuation was 2.4%. This signifi cant discrepancy indicates that the use of iodine disinfectant is a risk factor for delayed hyperthyrotropinemia in late preterm infants.
Very low birth weight (VLBW) infants had 14 times higher in cidence of transient hypothyroidism than infants weighing >1,500 g at birth, and most showed delayed TSH level elevation 2224) . In a 2015 study, 9.8% (24/246) of VLBW infants had elevated TSH level, and 91.6% of these (22/24) had delayed TSH level eleva tion 25) . Kaluarachchi et al. 26) also evaluated infants with GA <30 weeks and reported that 6.9% had congenital hypothyroi dism with delayed TSH level elevation. While it was difficult to com pare the given values due to varying TFT times and cutoff levels, the occurrence of delayed TSH level elevation in late pre mature infants during iodine administration was similar to those in previous studies including younger infants. This suggests a need for secondary TFTs for late preterm infants with a history of iodine disinfectant use.
Excessive iodine can cause thyrotropin level elevation 27) . Nor mally, when there is excessive iodine, thyroid iodine uptake and iodination of tyrosine cease production to prevent overpro duc tion of thyroid hormone. This defense mechanism, known as the WolffChaikoff effect, does not mature until 36 to 40 weeks' gesta tion. Furthermore, premature infants are exceedingly vulnerable to iodine exposure due to increased iodine absorption through permeable skin and delayed iodine excretion through the kid neys 28, 29) . Results from this study showed that 17 of 20 pati ents (85 %) with hyperthyrotropinemia were hospitalized during iodine disinfectant use. Additionally, Aitken and Williams 28) found that the incidence of hypothyroidism and hyperthyrotro pinemia was significantly higher in premature infants with GA <32 weeks (12% to 33%) and who were exposed to iodine disin fectants. Our results were similar to those of previous studies on extremely premature infants and showed that care should be taken when using iodine disinfectants in late preterm infants. If they must be used, follow up TFT is highly recommended.
In this study, we analyzed clinical differences in patients de pending on the period, as there was a higher proportion of male and SGA infants in period 1, but there were no differences in diseases or length of hospital stay. We also evaluated the number of patients who had central lines and the duration; this is because the frequency of disinfectant use may increase with central line insertion and maintenance 16) . However, we found no difference between the two periods. This evidence suggests that ordinary use of iodine disinfectants for culture testing or dress ings can affect thyroid function of late preterm infants. Other sources of iodine include not only iodine disinfectants used on mothers before delivery but also breast milk. For example, seaweed soup is traditionally consumed by Korean mothers postdelivery and is rich in iodine; therefore, we should also consider the effect of breastfeeding 30) . However, for the purpose of this study, this claim is unsubstantiated because urinary iodine concentration tests were never performed.
SGA was also a significant risk factor of thyroid dysfunction.
Bagnoli et al. 31 34) . Our results show that TSH level, which should decrease 2 weeks after birth, has a delayed elevation in late preterm infants and suggests a need for repeated tests. Several studies on VLBW infants showed delayed thyroid dysfunction approximately 3 weeks after birth 22, 23) .
Opinions vary regarding the recommended rescreening time for TFT, and these variances can range between 2 and 6 weeks after birth 14, 3537) . Hashemipour et al. 37) reviewed documentation on the screening process of preterm congenital hypothyroidism and suggested that repeated screening is necessary. A TSH level of 10 . Due to inconsistencies with researcher re commendations and vagueness of specific guidelines, it would be advantageous to execute largescale longitudinal studies that include longterm developmental followup.
The authors of this study recognize that there were significant limitations. First, this was a singlecenter study with a limited number of participants. Second, due to the retrospective nature of the study, we were unable to validate the exact iodine level in the body. Third, this study was conducted considering iodine exposure as a factor affecting thyroid function but did not include longterm developmental followup. Finally, many late preterm infants with acute problems necessitating NICU hospitalization were included, as we cannot eliminate the impact of illness on thyroid function. However, this study is significant in that it pro vides a basis for the necessity of secondary thyroid screening by illustrating the incidence of delayed thyrotropin level elevation in late preterm infants, as there are few studies on TFT of late pre term infants.
Therefore, our retrospective study reported that late preterm infants who were SGA or exposed to iodine disinfectants showed delayed thyrotropin level elevation with high incidence and identified the need for secondary TFT 2 to 4 weeks after birth. It is suggested that welldesigned, largescale studies are necessary to establish TFT guidelines for late preterm infants. We also con cluded that prospective research focused on the relationship between longterm neurodevelopment outcomes and TFT changes associated with iodine exposure and iodine levels in the body is needed.
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